Showing results (291-300 of 500) with videos related to

Sort By:
Pageof 50
Human Gene Therapy|May 6, 2005
Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functionsMarybeth S Hughes, Yik Y L Yu, Mark E Dudley, et al.
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Linking laboratory and clinical research: the development of molecularly targeted therapeutics inside the national cancer institute center for cancer researchJ Carl Barrett, L Michelle Bennett, Laura Kay Fleming, et al.
Human Gene Therapy|May 1, 2008
Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2Bianca Heemskerk, Ke Liu, Mark E Dudley, et al.
Science (New York, N.Y.)|April 15, 2017
Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancerSanja Stevanović, Anna Pasetto, Sarah R Helman, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2021
Breast Tangent Beam Energy, Surgical Bed-to-Skin Distance and Local Recurrence After Breast-Conserving TreatmentAlan Nichol, Dylan Narinesingh, Louise Wade, et al.
Antibiotics (Basel, Switzerland)|June 26, 2026
A Comprehensive In Vitro Assessment of Broad-Spectrum Antimicrobial Efficacy of Organo-Selenium-Incorporated Urinary Catheter in Comparison to a Zwitterionic Surface CatheterHarry May, Md Abid Afridi, Phat L Tran, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2021
The Effect of Bolus on Local Control for Patients Treated With Mastectomy and Radiation TherapyAlan Nichol, Dylan Narinesingh, Srinivas Raman, et al.
Cancer Immunology, Immunotherapy : CII|August 5, 2008
Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expressionJennifer A Wargo, Paul F Robbins, Yong Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 10, 2013
Collapse of the tumor stroma is triggered by IL-12 induction of FasSid P Kerkar, Anthony J Leonardi, Nicolas van Panhuys, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2013
Mutated PPP1R3B is recognized by T cells used to treat a melanoma patient who experienced a durable complete tumor regressionYong-Chen Lu, Xin Yao, Yong F Li, et al.
Pageof 50